ABSTRACT
INTRODUCTION
Various techniques have been developed for the detection of specific single-base mutations. Most widespread is the application of restriction fragment length polymorphism (RFLP) in conjunction with polymerase chain reaction (PCR) amplification. Wild-type and mutant DNA sequences are differentiated on the basis of different electrophoretic fragment patterns, which are due to the presence and absence of a specific restriction site. Yet, in most cases, there are neither wild-type-nor mutant-specific restriction enzymes available, and construction of restriction sites with PCR primers containing mismatches is not always straightforward. In addition, RFLP analysis sometimes necessitates the use of exotic, expensive restriction enzymes. Moreover, false-positive results can arise because of base substitutions at adjacent nucleotides.
These limitations have led to the development of several alternative methods for mutation detection, e.g., allele-specific hybridization (9) , reverse dot hybridization (10) , allele-specific PCR amplification (13) and DNA mini -sequencing (11) . However, each of these techniques has drawbacks and limitations, and their appropriate application depends on specific test requirements. Allele-specific hybridization, for example, typically requires separate wild-type-and mutant-specific reactions, including several processing steps, and is therefore most appropriate for large numbers of samples processed in parallel. Allele-specific PCR amplification is a fast alternative, but in most cases requires separate mutant-and wild-type-specific reactions and optimized reaction protocols, and is therefore not routinely applicable in multiplex assays. Furthermore, most of these techniques are not applicable for the quantitation of wild-type and mutant alleles.
To overcome these limitations we have developed a new fluorescencebased method, multiplex competitive primer extension (M-COP), which allows simultaneous nucleotide genotyping at several independent sites.
We have applied this technology to the detection of mutations in Leber's hereditary optic neuropathy (LHON), an ocular disease associated with distinct base substitutions in the mtDNA. Three mutations, G to A at nucleotide position (np) 3460 in the ND2gene (5), A to G at np11778 in the ND4gene (12) and T to C at np14484 in the ND6 gene (6) , are undoubtedly acknowledged as causal for the disease and account for about 90% of all cases of LHON in the caucasian population.
MATERIALS AND METHODS
Total DNA was extracted from whole blood samples by established techniques (8) . Oligonucleotides were purchased from MWG Biotech (Ebersberg, Germany) and PE Applied Biosystems (Weiterstadt, Germany) and purified by either HPLC or polyacrylamide gel electrophoresis (PAGE). Table 1 lists the primer sequences used in the assay. Wild-type-and mutantspecific oligonucleotides used in the primer extension reaction were coupled at their 5 ′ end with fluorescent dyes-FAM (5-carboxy-fluorescein) for wildtype-specific primers and JOE (2 ′ ,7 ′ -dimethoxy-4 ′ ,5 ′ -dichloro-6-carboxy-fluorescein) for mutant-specific primers, respectively-and contained an additional single-base mismatch to improve allele specificity.
Primary multiplex PCR amplification was performed in a 20-µ L reaction containing 80 ng total DNA, 12 pmol of primers C1 and C2, 4 pmol of primers C3 and C4, 8 pmol of primers C5 and C6, 10 mM Tris-HCl, pH 8.6, 3 mM MgCl 2 , 50 mM KCl, 200 µ M of each dNTP and 0.6 U AmpliTaq ® DNA Polymerase (Perkin-Elmer, Weiterstadt, Germany). After an initial denaturation of 1 min at 95°C, 30 cycles of 10 s at 94°C and 15 s at 60°C were performed, followed by a final extension step for 4 min at 72°C. Five microliters of the unpurified reaction products were combined with 0.25 pmol of primers AW and AM, 2.5 pmol of primers BW and BM and 1 pmol of primers CW and CM in a 10-µ L reaction volume including 0.4 U AmpliTaq. The reactions were incubated for 5 min at 95°C followed by three reaction cycles of 1 min at 94°C, 1 min at 48°C, 2 min at 72°C and a final extension step for 5 min at 72°C. All reactions were carried out in a GeneAmp ® PCR System 9600 Thermal Cycler (PerkinElmer). Three microliters of the final reaction product were mixed with 3 µ L formamide, denatured for 3 min at 90°C and loaded on a short (6-cm, well-to-read), 6% polyacrylamide/8 M urea gel running on a Model 373A DNA Sequencer (PE Applied Biosystems). Gel runs were analyzed with the GENESCAN™ 672 Version 1.2 software package (PE Applied Biosystems).
RESULTS AND DISCUSSION
The experimental strategy used for simultaneous nucleotide genotyping at the three LHON-specific nucleotide positions is outlined in Figure 1 . First, three non-overlapping fragments encompassing the critical nucleotide positions are simultaneously amplified from total DNA preparations (step 1). Three pairs of wild-type-and mutantspecific oligonucleotides, differing at the 3 ′ -most position and specified by different fluorescent dyes, are added, and a few rounds of competitive primer extension are performed (step 2). The final reaction products are separated on a denaturing polyacrylamide gel and detected fluorometrically (step 3). Wild-type or mutant genotype patterns are derived from the fragment length and the fluorescence dye color.
Conditions for the initial PCR amplification and the subsequent competitive primer extension reaction were optimized with respect to MgCl 2 concentration, primer length, primer concentration and cycling conditions to faciliate simultaneous analysis for the three mutation sites under investigation. Care was taken to: (i) select primers that give rise to similar but distinct product lengths in the primary PCR; (ii) position the ends of the primary amplification products so that the run-off primer extension products can be separated easily by size; and (iii) design PCR and extension primers with high specificity and little interference in the multiplex cocktail. No fewer than 12 primers (6 primers for the primary PCR and 3 wild-type/mutant pairs)
were present in the final competitive primer extension reaction. Under optimized conditions, the amplification of the three primary mtDNA fragments of 221 bp (np14360-np14581), 245 bp (np3274-np3518) and 273 bp (np11734-np12006) was nearly equally efficient (not shown).
The assay has been repeatedly tested on 27 subjects, each carrying one of the major LHON mutations in a homoplasmic fashion: 10 subjects harboring the np11778 mutation, 10 with the np3460 mutation and 7 with the np14484 mutation, respectively. In addition we included 20 control subjects that did not carry any of these mutations. Mutation sites in these subjects were indepen - Primer extension products from single individuals were separated on a 6% polyacrylamide/8 M urea gel on a Model 373A DNA Sequencer and analyzed with the GENESCAN software. Extension products corresponding to np11778, np3460 and np14484, respectively, can be seen from bottom to top. Wild-type genotypes are represented by blue color and mutant genotypes by green color. From left to right, four subjects mutant for np11778, four subjects mutant for np3460, four samples harboring the mutation at np14484 and four individuals carrying the wild-type alleles at all three nucleotide positions. dently confirmed by routine PCR/ RFLP analysis and direct DNAsequencing of PCR products. Figure 2 shows a screen picture of a typical gel run with individual samples in each lane. Extension products corresponding to a specific mutation site can be easily addressed by their particular fragment sizes: a 63-nucleotide product for np11778 (bottom), a 78-nucleotide product for np3460 (middle) and a 116-nucleotide product for np14484 (top). The corresponding genotype (presence of the wild-type or the mutant-type nucleotide) can be directly derived from the color of the extension product. The software decodes FAM dye (wild type) as blue color and JOE dye (mutant) as green color. By combining these data, a complete genotype with respect to all three major LHON mutations can be drawn up by inspection of a single lane.
The four dye-one lane technology allows the option to include an internal length standard for accurate fragment length calculations.
Representative single-lane electropherograms for wild-type and all classes of mutant DNA samples are shown in Figure 3, a-d . The graphs clearly indicate the high specificity and accuracy of the method. Although reaction conditions had to be adapted for simultaneous genotypic discrimination at three different sites, background peaks, due to extension of alternate primers, are well below critical levels. Peak sizes are reproducibly higher for the wildtype sequence than for the mutant sequence in the case of the primer pairs AW/AM (np11778) and CW/CM (np14484) and nearly equal for primer pair BW/BM (np3460). This behavior cannot be solely attributed to the increased thermal stability of primers carrying cytosine and guanine residues at their 3 ′ ends (primers AW, BW and CM). Sequence-dependent efficiency of polymerase binding and differences in the emission strength of the fluorescent dyes may also contribute to the actual peak height.
To test whether M-COP was suitable for quantitating amounts of mutant and wild-type molecules in heteroplasmic mtDNA samples, assays were performed with defined mixtures of primary PCR products of pure wild-type and mutant DNA samples. For np3460, observed mean values from 8 independent experiments, calculated as a simple quotient of wild-type and mutant peak areas, were very close to the expected values: 13.0% wild-type molecules observed/10% wild-type expected, 27.5%/ 25%, 54.1%/50%, 77.4%/75% and 90.4%/90%, respectively. Reliable and reproducible detection of the mutations was achieved for sample mixtures containing less than 10% (np3460) and less than 20% (np11778 and np14484) mutant primary PCR fragments, respectively (data not shown).
In addition, for all samples of subjects known to carry heteroplasmic mixtures of wild-type and mutant mtDNA molecules (5 probands for np3460 and 3 probands for np14484), heteroplasmy could be unequivocally detected in blind experiments. Figure  3e depicts a typical result for the detection of heteroplasmy at np3460.
These data indicate that M-COP is able to detect proportions of mutant mtDNA molecules, which allows at least the accurate diagnosis of symptomatic LHON patients. In addition, accurate quantitation can be achieved for the np3460 mutation within a broad range of wild-type/mutant content ratios.
In the initial report on the detection of mutations by competitive oligonucleotide priming, the authors used radiolabeled primers that limited the assay to the detection of a single allele per analysis (4) . With the implementation of wild-type-and mutant-specific primers labeled with different fluorescent dyes, discrimination between wild-type-and mutant-derived reaction products is possible on the basis of fluorescence emission. Competitive PCR amplification with fluorescence-coupled oligonucleotides has been reported for the detection of the dF508 mutation in the Cystic Fibrosis Transmembrane Conductance Regulator ( CFTR ) gene. But in this case, wild-type-and mutantspecific primers differ substantially in their primary sequences (3). Alternatively, allele-specific primers differing in length have been used, which require genotyping for different loci to be performed in separate PCRs (7) . By adapting the basic strategy of dyelabeled primer competition, we have improved this method for the differentiation of several single-base substitutions. The two-step procedure in our assay allows flexibility in the selection of appropriate primers and cycling conditions for the primary multiplex PCR and the utilization of high concentrations of specific templates for the selective primer extension step. There is no need to include any purification or concentration step either after the primary PCR or before gel electrophoresis. Therefore, performance of both reactions-primary PCR and competitive primer extension-in a single tube containing all primers may be feasible. The amplification of primary fragments may be accomplished with longer primers at an elevated thermal profile, followed by more ambient cycling conditions suitable for the annealing of the allele-specific primers. The use of different fluorescent dyes for the mutant-specific primers, which allows detection and discrimination by fluorography, may even obviate electrophoretic separation of the extension products (2), making the assay applicable to full automation.
The lack of any radioactive compounds makes M-COP an easy and safe procedure for routine applications. Running costs are low with fluorescence detection devices now accessible to many laboratories. With appropriately designed primers, development of single assays for other single-base alterations can be accomplished easily, particularly for the detection of simple homozygotic and heterozygotic conditions. However, multiplex assays may require careful selection of primers and optimization of the reaction conditions. Alternatively, samples from single assays may be pooled before gel electrophoresis.
As demonstrated here for the testing of mutations in LHON, M-COP is a method that is potentially suitable for use in many other diagnostic applications, particularly when fast, routine analysis of a few specific point mutations is desired.
